CHRNA4 and metabolic dysfunction-associated steatohepatitis: A recent study has demonstrated that Chrna4 expression is elevated in metabolic dysfunction-associated steatohepatitis (MASH) and that its activation promotes pro-inflammatory cytokine production contributing to the progression of liver inflammation.